Intellectual Property India Publishes Patent Application for Engineered Antibodies And Immunoconjugates And Methods Of Use

MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202617078160 A) filed by Aarvik Therapeutics, Inc. on June 24, 2026, for Engineered Antibodies And Immunoconjugates And Methods Of Use.

Inventors include Junutula, Jagath R.; Blazer, Levi L.; Adams, Jarrett; Bhakta, Sunil; and Sidhu, Sachdev Singh.

The application for the patent was published on September 18, 2026, under issue no. 38/2026.

Abstract: Provided herein are tetravalent antibodies and immunoconjugates in which the antibodies are conjugated with a payload. The antibodies can comprise a number of different architectures in which paratopes, formed as, for example, Fabs or diabodies, are positioned relative to each other and to an Fc region....